Cardiff Lexington Corp (CDIX) community

CDIXOTCServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 0/30

$0.04−0.01 (-25.53%)

Close on Oct 19, 2026Market cap $550.31KP/E –Yield –

Community

Notes and questions about Cardiff Lexington from other investors

No posts about CDIX yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Cardiff Lexington's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-3 reverse split on Jan 12, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CDIX.

Compare: CDIX vs BMGL · CDIX vs HLYK · CDIX vs SBC · CDIX vs EUDA · CDIX vs ALPS

Revenue growth-23.7% · median -26.8%

Operating margin-25.2% · median -65.1%

Net margin-126.4% · median -130.7%

Company	Revenue	Growth
SBC	$175.17M	-6.9%
CDIX	$9.07M	-23.7%
HLYK	$1.37M	-46.7%
BMGL	–	–
EUDA	–	–
ALPS	–	–

Company

Exchange: OTC
Industry: Services-Offices & Clinics of Doctors of Medicine
Fiscal year ends: December 31
Employees: 18
Auditor: GBQ Partners, LLC
SEC CIK: 811222

Advertisement
300 × 250

See a number that looks wrong?